Secreted Non-Coding RNAs: Functional Impact on the Tumor Microenvironment and Clinical Relevance in Triple-Negative

Silvia Di Agostino1, Mahrou Vahabi2, Chiara Turco2

  • 1Department of Health Sciences, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy.

Non-Coding RNA
|January 25, 2022
PubMed

Insights

Secreted non-coding RNAs (ncRNAs) play a crucial role in triple-negative breast cancer (TNBC) progression and treatment resistance. These molecules, found in circulation, show promise as non-invasive diagnostic and prognostic biomarkers for TNBC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Triple-negative breast cancer (TNBC) presents a poor prognosis and high metastatic potential due to a lack of targeted therapies.
  • Current TNBC treatments rely on chemotherapy, radiotherapy, and surgery, with limited success in precision medicine.
  • Non-coding RNAs (ncRNAs) are increasingly recognized for their role in TNBC's oncogenic processes, including proliferation, invasion, and angiogenesis.

Purpose of the Study:

  • To review the role of secreted circulating ncRNAs in intercellular communication within the tumor microenvironment (TME) of TNBC.
  • To explore the potential of these ncRNAs as diagnostic and prognostic non-invasive biomarkers for TNBC patients.
  • To highlight novel insights into how ncRNAs contribute to TNBC progression and treatment resistance.

Main Methods:

  • Literature review focusing on the function and detection of secreted ncRNAs in TNBC.
  • Analysis of studies investigating the impact of ncRNAs on tumor microenvironment components.
  • Examination of research on the diagnostic and prognostic value of circulating ncRNAs in TNBC.

Main Results:

  • Secreted ncRNAs are implicated in driving proliferation, invasion, and angiogenesis in TNBC.
  • These ncRNAs modulate immune and stromal cell activity within the TME.
  • Circulating ncRNAs in serum/plasma are emerging as promising biomarkers for TNBC detection and prognosis.

Conclusions:

  • Secreted circulating ncRNAs are key mediators of intercellular communication in the TNBC TME.
  • These molecules represent a significant advancement in the development of non-invasive diagnostic and prognostic tools for TNBC.
  • Targeting or utilizing these ncRNAs may offer novel therapeutic strategies for TNBC management.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.9K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
69.1K